Devansh Trademart LLP, a promoter of Gujarat Fluorochemicals, divested a 1.18 percent stake in the company for ₹460 crore through an open market transaction on Wednesday. Following this sale, its holding in Gujarat Fluorochemicals has decreased from 4.84 percent to 3.66 percent. The overall promoters’ stake has also declined, from 62.58 percent to 61.4 percent.
SBI Mutual Fund acquired 10,73,424 shares, representing a 2.85 percent stake in Pitti Engineering, for approximately ₹102 crore. These shares were purchased at an average price of ₹950.10.
Smartworks Coworking Spaces Ltd has leased 5.57 lakh sq ft of office space in Mumbai to establish a significant center in response to the rising demand for flexible managed workspaces from corporations. The company announced the signing of a lease for over 5,57,000 sq ft at Intellion Park, Navi Mumbai, a project by Tata Realty and Infrastructure Ltd. This site will be Smartworks’ largest managed office campus in Mumbai, and the company’s total leased portfolio in the city has now surpassed 10 lakh sq ft.
Dreamfolks Services has ceased its domestic airport lounge services amid various challenges, leading to a nearly 5 percent drop in its share price on Wednesday. The company stated, “The services of domestic airport lounges have been discontinued to our clients, effective today. The impact of the same is material,” but confirmed that other domestic services and its global lounge business will continue as normal.
Rajendra Lodha, a former director of Lodha Developers (previously known as Macrotech Developers), was arrested for allegedly defrauding the firm of ₹85 crore. His resignation followed an ethics review, and he is accused of fraudulent land transactions. He is currently in police custody until September 23, as investigations proceed. Lodha Developers maintains a “zero-tolerance policy towards any misconduct, irrespective of the seniority or position of the individual concerned.” Lodha resigned from all positions at the company on August 17.
Cochin Shipyard Limited has signed a contract with ONGC for the dry dock major lay-up repair of one of ONGC’s jack-up rigs, valued at about ₹200 crore, to be completed over 12 months. The company confirmed that the order does not involve any related-party transactions and has officially disclosed the award to stock exchanges.
Market rumors suggest that Jusmiral Holdings, a shareholder in Cohance Lifesciences (formerly Suven Pharmaceuticals), plans to sell up to 5.1 percent of its stake through block deals, estimated at ₹1,756 crore with a floor price of ₹900 per share.
Adani Enterprises’ subsidiary, Adani Airports Holdings Ltd (AAHL), announced a series of digital initiatives aimed at improving passengers’ travel experiences across its airports. This announcement precedes the forthcoming inauguration of the Adani Group-owned Navi Mumbai International Airport, which is expected to be inaugurated later this month by Prime Minister Narendra Modi. The group currently operates seven airports including those in Mumbai, Ahmedabad, and Jaipur.
TVS Motor Company has collaborated with connected lifestyle brand Noise to integrate its electric vehicles with smartwatches, enabling riders to connect with their vehicles. This integration allows the TVS iQube electric scooter to communicate with a special edition Noise smartwatch designed to provide real-time updates such as vehicle status, battery information, tire pressure, and safety alerts.
Thomas Cook India announced that its Non-Executive Chairman and Director, Madhavan Menon, has resigned effective September 17. Menon expressed a desire to leave the organization and pursue other interests as part of his retirement plans, according to a regulatory filing.
Hyundai Motor India declared on Wednesday that it will increase employee compensation by ₹31,000, effective from April 1, 2024, to March 31, 2027. The company and the United Union of Hyundai Employees (UUHE) finalized a wage settlement agreement for this period, which applies mainly to the technician/workmen cadre.
Biocon Biologics Ltd, a Biocon subsidiary, announced that it has received US FDA approval for its denosumab biosimilars: Bosaya, a Prolia biosimilar targeting osteoporosis and cancer-related bone loss, and Aukelso, a Xgeva biosimilar meant for addressing skeletal complications in cancer patients and other bone-related conditions.
Published on September 18, 2025
